Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-068690
Filing Date
2011-03-16
Accepted
2011-03-16 16:15:52
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1201149
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1972
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1992
4 CERTIFICATION OF PEO AND PFO PURSUANT SECTION 302 dex311.htm EX-31.1 6908
5 CERTIFICATION OF PEO AND PFO PURSUANT SECTION 906 dex321.htm EX-32.1 3200
6 GRAPHIC g157462g07n88.jpg GRAPHIC 47366
7 GRAPHIC g157462g26h80.jpg GRAPHIC 42930
  Complete submission text file 0001193125-11-068690.txt   1341127
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31141 | Film No.: 11692040
SIC: 2834 Pharmaceutical Preparations